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Abstract 
Treatment modalities for newborns with anatomical congenital anomalies have greatly 
improved over the past decades, with a concomitant increase in survival. This review will 
briefly discuss specific long-term outcomes to illustrate which domains deserve to be 
considered in long-term follow-up of patients with anatomical congenital anomalies. Apart 
from having disease-specific morbidities these children are at risk for impaired 
neurodevelopmental problems and school failure which may affect participation in society in 
later life. There is every reason to offer them long-term multidisciplinary follow-up 
programs. We further provide an overview of the methodology of long-term follow-up, its 
significance and discuss ways to improve care for newborns with anatomical congenital 
anomalies from childhood into adulthood. Future initiatives should focus on transition of 
care, risk stratification and multicenter collaboration. 
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Introduction 
Treatment modalities for newborns with anatomical congenital anomalies (CA) have greatly 
improved over the past decades, with a concomitant increase in survival. For many pediatric 
surgical index diagnoses, mainly children born with multiple congenital anomalies are now at 
risk of early mortality. Even for congenital diaphragmatic hernia (CDH) mortality rates have 
decreased from 50% to approximately 25%(1), supported by the success of a new 
standardized postnatal treatment protocol.(2, 3) 
Now more of these critically ill children survive, clinicians are confronted with an increasing 
number of patients who suffer from long-term morbidities, not only in childhood but also in 
adulthood. Their interest has therefore shifted from reduction of mortality towards 
prevention of morbidity. 
Historically, outcome studies on morbidity in pediatric surgical patients have focused on 
direct disease-related morbidity or evaluation of surgical techniques. However, it has 
become clear that long-term outcome is largely determined by morbidities indirectly related 
to the anatomical CA, to the treatment or to the natural course of the disease and its impact 
on family life. 
This review will only briefly discuss specific long-term outcomes as many of these will be 
reviewed by other authors who contribute to this special issue. The outcomes mentioned 
will serve to illustrate which domains deserve to be considered in long-term follow-up of 
patients with anatomical CA. We further provide an overview of the methodology of long-
term follow-up, significance of follow-up and discuss ways to improve care for newborns 
with anatomical CA from childhood into adulthood.  
 Methodology of long-term follow-up: 
For a long time, follow-up programs for patients with anatomical CA have been using a 
monodisciplinary individualized approach based on the patient’s condition. In the 1990s the 
first multidisciplinary clinics for patients with anatomical CA were established.(4, 5) Despite 
that many centers acknowledge the importance of long-term follow-up, e.g. for patients 
with CDH or anorectal malformations (ARM), only few offer structured follow-up beyond the 
first years of life.(6, 7) Study designs such as a cross-sectional study or retrospective chart 
review in individually treated patients are insufficient to understand the natural course of 
disease and result in selection bias. 
Standardization of follow-up 
As descriptive studies with an observational design use structured and validated instruments 
to collect data, they can easily be performed within the infrastructure of routine patient 
care. Ideally, data are collected at moments that are medically relevant or dictated by 
guidelines(8) and at developmental milestones (e.g. speech-language development or 
voluntary bowel movement control). Additional tailor-made assessments should be offered 
to individual patients. 
Outcome data of children with anatomical CA are ideally compared with those of matched 
healthy controls. However, longitudinal assessment of healthy controls from the neonatal 
period into adolescence or adulthood is hardly feasible. Instead, well validated standardized 
instruments with published data of an appropriate reference population should be used.  
Assessments during follow-up 
Evaluation of physical growth is simple and important to provide information on the child’s 
nutritional status. Chronic malnutrition – defined as height at least 2 SD below the norm – 
has been assumed to be related to adverse intellectual outcomes.(9) Early growth 
impairment should be closely monitored and timely referral to a dietician for nutritional 
assessment and intervention is then indicated.(10) This is not only important for CDH 
patients(10) but also for children with other anatomical CA such as esophageal atresia 
(EA)(11) and ARM(12) who are at risk for growth impairment. 
For many different countries national growth charts are available. Alternatives are the Euro 
Growth references(13) or the World Health Organization (WHO) growth charts.(14, 15) 
While differences in height-for-age charts from different European countries may reflect 
true population differences, they also strongly affected by the secular trend in height. 
Therefore, it is recommended to use national or European height-for-age charts based on 
recent national data to monitor growth of European children.(16) 
For children who suffer from long-term pulmonary morbidity, such as seen in CDH, EA, 
congenital lung malformations or giant omphalocele, longitudinal spirometry testing before 
and after bronchodilation may be useful. Appropriate standards for lung function testing and 
multi-ethnic reference data from 3 to 95 years are available.(17, 18) Assessment of 
reversibility of airflow obstruction may be important because reversibility has therapeutic 
consequences. Exercise tests may be useful to evaluate pulmonary condition and fitness as 
well. For example, the six-minute walk test is suitable for children from the age of 3 years.  
This test was originally developed to measure the submaximal level of functional capacity in 
adults with moderate to severe cardiopulmonary diseases. A recent systematic review 
revealed that studies of children with chronic conditions assessed with the six-minutes walk 
test use many different test procedures. Based on current literature it is unclear whether the 
six-minute walk test can measure significant and important changes in children.(19) 
Moreover, it reflects an exercise level close to that of daily life activities rather than that of 
exercise endurance. A maximal exercise test, such as cycle ergometry or a treadmill test (e.g. 
Bruce protocol) is likely to provide better information on the pulmonary condition in 
children with anatomical CA.  A treadmill test is preferred in younger children with relatively 
underdeveloped knee extensors.(20) Recent population-appropriate reference data should 
be used because the maximal exercise capacity of healthy 6-10-year-old children has 
deteriorated over the past decades. It is thought that spending more time playing computer 
games and watching television have a role here.(21) Recent studies have shown that 
children with CDH and EA are at risk for reduced maximal exercise capacity(22, 23) but the 
reason is not yet clear. 
Research has shown that children born with anatomical CA are at risk for 
neurodevelopmental problems, although some of the findings are contradictory. Research 
initially focused on developmental outcomes within the first years of life(5, 24-26) but more 
data have become available on long-term developmental outcomes up till school age.(12, 
27-33) The first publications on long-term outcome suggested that short-term outcomes of 
children born with non-cardiac anatomical CA were predictive of their long-term 
neurodevelopmental outcome. (28). It was then found, however, that many of 8-year-old 
ECMO-treated CDH patients needed extra help at school despite that assessments at two, 
five or eight years showed average intelligence which remained stable over time.(34) The 
necessity of extra help was attributed to selective attention problems.(34) Selective 
attention problems have been reported in other groups of children with anatomical CA as 
well.(31, 32) All this highlights the importance of multidisciplinary follow-up at school age 
and beyond. 
Age-appropriate developmental tests are available for different stages in life. It is essential 
to use standardized tests with suitable reference norms, considering that healthy Australian 
children on average showed significantly higher on the 3rd version of Bayley Scales of Infant 
and Toddler Development (BSID-III) than did the US reference population.(35) For 
longitudinal assessments or multicenter studies attention should be paid to using the 
appropriate test version. Many items of the BSID-III, for example, differ from the 
corresponding ones in the BSID-II(36), which may have contributed to the difficulties in 
interpreting outcome data of a European multicenter study in CDH patients.(37) 
Points of concern in long-term follow-up  
When performing population-based studies on long-term outcome in children with 
anatomical CA several potential pitfalls need to be addressed. The first is risk of selection 
bias. Parents of children with only minor morbidities will be less motivated to visit the 
hospital for routine evaluation.(38) On the other hand, for children with severe long-term 
morbidities, e.g. oxygen dependency in CDH-patients, travel distances may be too long. For 
these categories of patients additional data should be retrieved from community-based 
healthcare services or from other hospitals. Also, among children referred to 
multidisciplinary teams specialized to treat specific problems – e.g. aerodigestive teams for 
EA patients – children prone to develop airway infections or feeding difficulties may be 
overrepresented.(39) 
The second pitfall is risk of loss to follow-up. We have noted that parents are motivated to 
have their child attend follow-up programs if they feel that it is of benefit to the child. 
Receiving a report with positive evaluation results may also be important in this respect for 
parents and children. On the other hand, 5-10% of children with severe disabilities may not 
be able to undergo standardized tests for motor function evaluation or routine 
neurodevelopmental tests.(30) The latter group is usually not included in the overall 
evaluations of treatment modalities, which may result in too optimistic reporting and also 
contributes to risk of selection bias. 
 
Clinicians looking into long-term outcomes may tend to focus on disease-specific outcomes 
first. Everyone taking care of children with anatomical CA will realize that those with specific 
genetic syndromes – such as trisomy 21 or Charge syndrome – may be at risk for 
neurodevelopmental problems and growth failure. This subgroup of patients is usually well 
being cared for. However, fewer clinicians may be aware of the more “hidden” morbidity 
which may affect long-term quality of life of children with anatomical CA and their families. 
The interactive behavior of mothers of infants with EA was affected during feeding in the 
sense that they showed more insensitivity, inconsistency, and anxiety.(40) Almost one third 
of these infants showed infant mental health disorders at one year of age.(41)  
Early relational trauma is suggested to be a causative factor of abnormal development of the 
right hemisphere(42), which is important in all visual-spatial functions. A recent study 
showed that school-aged children with anorectal malformations have more problems with 
visual-spatial sustained attention and perceptional organization.(32) Extensive medical 
treatment to obtain the best possible anorectal function, including frequent anal calibration 
by the parents, is suggested to be a risk factor for early relational trauma and this risk should 
be further studied.(32) Moreover, anal calibration performed in ARM patients has been 
found a risk factor for persistent dissociative symptomatology in adolescence and 
adulthood.(43) Dissociative symptoms may contribute to impaired psychosexual well-being, 
as was reported for adult patients with colorectal anatomical CA. Still, further studies are 
needed to determine the exact cause of psychosexual problems in these patient groups.(44) 
All these examples illustrate that the natural course of anatomical CA is complex and that 
many contributing factors have to be taken into account in the evaluation of long-term 
outcomes. These factors also include more general medical problems associated with long-
term morbidities, such as preterm birth and/or being born small for gestational age, and 
which are more common in children with birth defects.(45) 
Importance of long-term follow-up 
From the clinicians’ perspective it is important to know about long-term morbidities for 
several reasons. Firstly, as pointed out in the introduction to this chapter, more children with 
severe anatomical CA will survive and they may problems that were never encountered in 
the past. For example, young adult CDH patients who had been ventilated in the neonatal 
period for a median period of 7 days showed functional and micro-structural changes in 
mainly the ipsilateral lung. These changes were more profound in an ECMO-treated patient 
who had been ventilated for 141 days.(46) The question is whether future CDH survivors will 
show more severe structural pulmonary changes influencing daily life and social 
participation. Secondly, evaluation of long-term effects of treatment interventions is 
important. Functional outcomes may be related to treatment, e.g. motor function after 
application of the component separation technique in children with giant omphalocele(33); 
neurodevelopmental outcome following exposure to severe hypercapnia and acidosis during 
minimal invasive surgery in CDH(47); or lung function testing to evaluate the effects of 
different initial ventilation strategies in CDH patients.(48) In this respect, evaluation of long-
term outcomes after implementation of standardized postnatal treatment protocols(37) is 
important too.  
From the patients’ perspective, knowledge on long-term morbidities will help to recognize 
problems at an early stage so that timely intervention can be offered. For instance, referral 
to a pediatric physical therapist in the case of persistent gross motor function problems that 
have implications for everyday activities(31). Explaining long-term outcomes to the child, its 
parents and other caregivers will have a stimulating effect on care domains such as self-
management, family empowerment, and education. Awaiting further research, we 
hypothesize that long-term follow-up programs are cost-effective as family empowerment is 
expected to improve outcome(49) and education of other caregivers may result in targeted 
evaluation without redundant tests. Moreover, outcome research data can form a basis for 
randomized clinical trials that lead to improved care (Figure). 
Future perspectives and challenges 
Transition of care 
The substantial number of recent studies on outcome of CA in adulthood(44, 46, 50-55) 
indicates that clinicians pay more attention to long-term outcomes and to transition of 
care.(56) Nevertheless, facilitating the transition from pediatric to adult services is still not 
considered as standard of care. A survey on transition of ARM patients among delegates 
who attended a colorectal meeting showed that one third of respondents routinely 
suspended follow-up before the age of 10 years and that 72% did not have a protocol for 
transition.(7) The American Academy of Pediatrics recommends post-discharge follow-up of 
CDH patients up to the age of 16 years but not beyond that age.(8) In view of the current 
knowledge on possibly unfavorable long-term outcomes we recommend that follow-up 
programs include transition of adolescent patients to adult care. Optimal schedules for 
multidisciplinary care should be based on standardized outcome research and be supported 
by international consensus guidelines.(57) 
Risk stratification 
Risk stratification is helpful to determine which patients should be followed more closely and 
which less closely. Many different aspects have to be considered. These include disease-
specific factors, comorbidities and complications, illness severity, and – especially for 
neurodevelopmental outcome – general factors such as length of hospital stay, parental 
socio-economic status, and nature of the parent-child interaction. The potential 
neurotoxicity of anesthetic drugs in the neonatal period has been addressed in recent 
literature(58) and may be of interest for future evaluations as all neonates born with 
anatomical CA are exposed  to such drugs. Interaction between all above-mentioned factors 
contributes to the problem of discriminating specific risks for poor long-term outcome. The 
published independent determinants of neurodevelopmental outcome(5, 28, 29, 31, 37, 59) 
should be considered with some caution as these are mainly derived from single-center 
studies with relatively small study populations. As multicollinearity in regression analyses is 
more likely to occur in small sample sizes, establishing independent risk factors for poor 
outcome is more complicated. Multicenter studies may be helpful on the one hand to create 
larger sample sizes, but may be challenging on the other hand because standardized 
assessment instruments and appropriate reference data are needed.(37) The use of a 
standardized clinical assessments and management plans (SCAMP) seems a promising novel 
approach for future collaboration between centers to assess long-term outcomes and to 
discriminate risk factors for poor outcome within the different domains.(60) Initially, all 
patients with a specific CA should be evaluated according to the same assessment plan, the 
outcome of which may show whether  all or part of the assessments in “low-risk patients” 
can be done by community-based healthcare providers.  
The contribution of international registries 
Several international registries have been established with the aim to assess therapies or 
outcome improvement measures in CDH(61) and ARM.(62) In addition, efforts have been 
undertaken to standardize reporting systems.(1, 62) Still, apart from the challenges reviewed 
by Jenetzky and co-workers for the ARM-Net Registry(62), some other issues need to be 
resolved on the way to uniform data collection in a multicenter international registry of long-
term outcome data. First, postnatal treatment protocols need to be standardized. Although 
registered long-term outcome data may be useful to compare different postnatal treatment 
strategies, a minimum set of uniform treatment criteria and a substantial number of 
participating centers for detection of statistically significant differences is required. Second, 
assessment instruments and outcome scores need to be standardized and validated. Ideally, 
population specific standard deviation scores are obtained. Third, sufficient resources must 
be ensured, not only to make long-term follow-up possible, but also to set up registries 
meeting the institutional criteria of data management for all participants and to maintain 
registries both at a local and a central level. 
In conclusion, the management of the wide range of long-term morbidities seen in children 
with anatomical CA is a task that cannot be fulfilled by the pediatric surgeon alone. Apart 
from having disease-specific morbidities that may also deserve a multidisciplinary approach 
including transition to adult services, these children are at risk for impaired 
neurodevelopmental problems and school failure which may affect participation in society in 
later life. There is every reason to offer them long-term multidisciplinary follow-up programs 
that address a wide range of topics (Table). Achieving optimal risk stratification as well as 
tailor-made and standardized follow-up programs requires multicenter efforts with a focus 
on uniformity of treatment and assessment protocols, standardized instruments and data 
management. The extra expenses needed for evaluation of outcome data should pay 
themselves off by improvement of care with concomitant reduction of the burden on the 
health care system. 
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Figure Legend: 
Schematic representation of a standardized multidisciplinary approach to optimize care for 
patients with anatomical congenital anomalies. RCT = randomized controlled trial 
    
 
  
Table:  Topics to be addressed in multidisciplinary long-term follow-up of children born with 
anatomical congenital anomalies 
 Specific topics Relevance/intervention 
Infancy Growth 










Referral preverbal speech-language pathologist 
Psychological support 
Specific intervention if indicated 
Early recognition, rehabilitation, genetic 
counseling 
Early recognition, rehabilitation, genetic 
counseling 
Referral physical therapist 
Organ-specific intervention if indicated  
Toddler/preschool age Growth  







Motor function development 
Associated anomalies 
Hyperalimentation 
Referral preverbal speech-language pathologist 
Psychological support 
Specific intervention if indicated 
Rehabilitation, genetic counseling 
Referral speech-language pathologist 
Early recognition, rehabilitation, genetic 
counseling 
Referral physical therapist 
Organ-specific intervention if indicated 
School age Growth  
Feeding difficulties 
Disease-specific morbidity 




Hyperalimentation, dietary advice 
Management based on cause 
Specific intervention if indicated 
Referral physical therapist, sports participation 
Early school support 
Early intervention, psychological support 










Transition to adult care 
Hyperalimentation, dietary advice  
Management based on cause 
Specific intervention if indicated 
School support, choice of profession/career 
Psychological support 
Organ-specific intervention and transition of 
care if indicated 
Involvement of disease-specific health care 
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